VISN

Vistance screens absurdly cheap — a 1.3 P/E, $9.63 diluted EPS, and net income up 823.8% to $2.28B — but the filing explains why none of that is real. FY2025 net margin is 118.2% (net income exceeds revenue), an arithmetic impossibility for an operating business; it is driven by gains on the long string of divestitures the MD&A details (the Home business, OWN segment, DAS unit, OneCell, and the CCS segment that closed January 9, 2026). The earnings power that actually recurs is operating income of just $47.6M on $1.93B of revenue — a 2.5% operating margin. Capitalizing that against a $2.90B equity value sitting on top of $7.26B of long-term debt (enterprise value near $9.4B) is the opposite of cheap; the headline multiple is a trap.

The balance sheet is the core problem. Stockholders' equity is negative at -$1.00B against a -$3.04B accumulated deficit, and total liabilities of $9.10B dwarf $9.37B of assets. Equity holders are a thin residual behind a large, structurally levered creditor stack, and $47.6M of operating income provides almost no cushion to service $7.26B of debt. Management openly frames the business as a multi-year 'transformation initiative' running since 2021, still incurring restructuring ($19.7M) and transaction/transformation costs ($29.9M) in 2025 with more 'material' charges flagged for 2026 — this is a company being dismantled and reassembled, not compounding.